アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

merck serono limited - metformin hydrochloride - powder for oral solution - 500 milligram

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - esomeprazole - gastro-resistant tablet - 40 milligram(s) - esomeprazole

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - esomeprazole - gastro-resistant tablet - 20 milligram(s) - esomeprazole

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

imed healthcare ltd. - quetiapine fumarate - tablet prolonged release - 50 milligram

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - lisinopril dihydrate - tablet - 20 milligram(s) - ace inhibitors, plain; lisinopril

マルタ - 英語 - Medicines Authority

abbott healthcare products limited - pancreatin 300 mg - capsule

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - pancreas powder - gastro-resistant capsule - 400 milligram(s) - enzyme preparations; multienzymes (lipase, protease etc.)

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

astrazeneca pharmaceuticals lp - bicalutamide (unii: a0z3nau9dp) (bicalutamide - unii:a0z3nau9dp) - bicalutamide 50 mg - casodex 50 mg daily is indicated for use in combination therapy with a luteinizing hormone-releasing hormone (lhrh) analog for the treatment of stage d2 metastatic carcinoma of the prostate. casodex 150 mg daily is not approved for use alone or with other treatments [see clinical studies (14.2)]. casodex is contraindicated in: casodex is contraindicated in any patient who has shown a hypersensitivity reaction to the drug or any of the tablet’s components. hypersensitivity reactions including angioneurotic edema and urticaria have been reported. casodex has no indication for women, and should not be used in this population. casodex can cause fetal harm when administered to a pregnant woman [see use in specific populations (8.1)] . risk summary casodex is contraindicated for use in pregnant women because it can cause fetal harm. casodex is not indicated for use in females. there are no human data on the use of casodex in pregnant women. in animal reproduction studies, oral administration of bicalutamide to p

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

atnahs pharma uk ltd - lisinopril - oral tablet - 5mg

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - bicalutamide - oral tablet - 50mg